Im Cannabis Operating Income Over Time
| IMCC Stock | USD 1.19 0.02 1.65% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Im Cannabis Performance and Im Cannabis Correlation. Will Biotechnology sector continue expanding? Could IMCC diversify its offerings? Factors like these will boost the valuation of Im Cannabis. Market participants price IMCC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Im Cannabis data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.48) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Im Cannabis Corp requires distinguishing between market price and book value, where the latter reflects IMCC's accounting equity. The concept of intrinsic value - what Im Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Im Cannabis' price substantially above or below its fundamental value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Im Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare Im Cannabis Corp and related stocks such as Akanda Corp, Redhill Biopharma, and Shuttle Pharmaceuticals Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AKAN | (901.2 K) | (901.2 K) | (901.2 K) | (901.2 K) | (901.2 K) | (901.2 K) | (901.2 K) | (901.2 K) | (901.2 K) | (901.2 K) | (1.7 M) | (2.6 M) | (20.2 M) | (10.1 M) | (4.4 M) | (3.9 M) | (4.1 M) |
| RDHL | (1.7 M) | (7.9 M) | (9 M) | (10.8 M) | (10.6 M) | (22 M) | (30.5 M) | (52 M) | (39.3 M) | (43.2 M) | (63.7 M) | (81.1 M) | (42.8 M) | 12.6 M | (14.6 M) | (13.2 M) | (13.8 M) |
| SHPH | (203.9 K) | (203.9 K) | (203.9 K) | (203.9 K) | (203.9 K) | (203.9 K) | (203.9 K) | (203.9 K) | (586.6 K) | (509.5 K) | (509.5 K) | (1.7 M) | (2.3 M) | (5.9 M) | (7.7 M) | (6.9 M) | (6.6 M) |
| MOVE | 5 M | 6.7 M | 5.2 M | 561 K | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (8.5 M) | (11.1 M) | (19.8 M) | (30.5 M) | (29.7 M) | (24.2 M) | (21.8 M) | (20.7 M) |
| JAGX | (22.2 M) | (8.3 M) | (8.3 M) | (8.3 M) | (8.3 M) | (12.4 M) | (13.6 M) | (34.2 M) | (30.8 M) | (28.9 M) | (26.6 M) | (40.7 M) | (34.4 M) | (34.3 M) | (30.8 M) | (27.7 M) | (29.1 M) |
| NDRA | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.6 M) | (1.8 M) | (4.6 M) | (9 M) | (10.8 M) | (11.5 M) | (11.5 M) | (13.2 M) | (10.5 M) | (10.8 M) | (9.7 M) | (10.2 M) |
| VERO | (20.5 M) | (20.5 M) | (20.5 M) | (20.5 M) | (20.5 M) | (20.5 M) | (18.9 M) | (17.3 M) | (25.9 M) | (20.3 M) | (40.4 M) | (17.5 M) | (34.9 M) | (28.3 M) | (27.2 M) | (24.5 M) | (25.7 M) |
Im Cannabis Corp and related stocks such as Akanda Corp, Redhill Biopharma, and Shuttle Pharmaceuticals Operating Income description
Operating Income is the amount of profit realized from Im Cannabis Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Im Cannabis Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Im Cannabis Corp | IMCC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Kibbutz Glil Yam, |
| Exchange | NASDAQ Exchange |
USD 1.19
Check out Im Cannabis Performance and Im Cannabis Correlation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Im Cannabis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.